Published in JAMA on December 15, 2010
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol (2007) 4.03
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol (2004) 2.22
Treatment of intrathoracic esophageal anastomotic leaks by means of endoscopic stent implantation. Interact Cardiovasc Thorac Surg (2010) 2.12
Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging (2007) 1.95
Heterotopic gastric mucosa of the esophagus: literature-review and proposal of a clinicopathologic classification. Am J Gastroenterol (2004) 1.83
Risk of stent-related aortic erosion after endoscopic stent insertion for intrathoracic anastomotic leaks after esophagectomy. Ann Thorac Surg (2011) 1.77
Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol (2012) 1.61
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg (2007) 1.56
Stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy. Surg Endosc (2007) 1.54
Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol (2005) 1.53
Eosinophilic esophagitis with severe GERD. Am J Gastroenterol (2009) 1.47
Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux. J Clin Gastroenterol (2005) 1.46
Pattern of lymphatic spread of Barrett's cancer. World J Surg (2003) 1.46
A new era in esophageal diagnostics: the image-based paradigm of high-resolution manometry. J Am Coll Surg (2009) 1.28
Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res (2005) 1.25
Oesophageal cancer--an overview. Nat Rev Gastroenterol Hepatol (2013) 1.18
Endoscopic stent insertion versus primary operative management for spontaneous rupture of the esophagus (Boerhaave syndrome): an international study comparing the outcome. Am Surg (2013) 1.17
Improved prognosis of resected esophageal cancer. World J Surg (2004) 1.14
Management of ERCP-related small bowel perforations: the pivotal role of physical investigation. Can J Surg (2012) 1.14
Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Trans R Soc Trop Med Hyg (2008) 1.11
For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story! Ann Surg (2013) 1.08
Surgical management of esophagogastric junction tumors. World J Gastroenterol (2006) 1.08
Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am (2006) 1.08
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer (2007) 1.07
Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog (2006) 1.07
Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol (2005) 1.07
Management of anastomotic leakage-induced tracheobronchial fistula following oesophagectomy: the role of endoscopic stent insertion. Eur J Cardiothorac Surg (2012) 1.06
Caspase-1 mediates resistance in murine melioidosis. Infect Immun (2009) 1.04
Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues. Clin Cancer Res (2007) 1.04
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT. J Nucl Med (2014) 1.02
How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol (2011) 1.00
Late hypopharyngo-esophageal perforation after cervical spine surgery: proposal of a therapeutic strategy. Eur Spine J (2005) 0.99
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res (2005) 0.99
Closure of persisting air leaks in patients with severe pleural empyema--use of endoscopic one-way endobronchial valve. Eur J Cardiothorac Surg (2010) 0.97
Diarrhea associated with afatinib: an oral ErbB family blocker. Expert Rev Anticancer Ther (2013) 0.96
Surgical therapy for necrotizing pneumonia and lung gangrene. Thorac Cardiovasc Surg (2012) 0.94
Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol (2004) 0.93
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center. Eur J Cancer (2013) 0.93
Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods (2009) 0.93
Giant pulmonary hamartoma--a rare presentation of a common tumor. Ann Thorac Surg (2006) 0.90
Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery (2002) 0.90
Preclinical trial of a modified gastroscope that performs a true anterior fundoplication for the endoluminal treatment of gastroesophageal reflux disease. Surg Endosc (2009) 0.89
Association of kyphosis and spinal skeletal abnormalities with intrathoracic stomach: a link toward understanding its pathogenesis. J Am Coll Surg (2009) 0.89
The impact of roux limb length on weight loss after gastric bypass. Obes Surg (2007) 0.89
Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg (2003) 0.88
Cholecystectomy in the very elderly--is 90 the new 70? J Gastrointest Surg (2011) 0.88
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology. Eur J Nucl Med Mol Imaging (2014) 0.88
VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg (2007) 0.88
Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease. J Gastrointest Surg (2009) 0.88
Peripheral primitive neuroectodermal tumor of the thymus. Interact Cardiovasc Thorac Surg (2010) 0.87
Circular dichroism in the photoelectron angular distributions of camphor and fenchone from multiphoton ionization with femtosecond laser pulses. Angew Chem Int Ed Engl (2012) 0.87
Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus. World J Surg (2003) 0.87
Risk of stroke for carotid endarterectomy patients with contralateral carotid occlusion. Ann Vasc Surg (2008) 0.86
Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol (2002) 0.86
Esophageal cancer surgery in heart transplant patients. Ann Thorac Surg (2005) 0.86
c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression. Neoplasia (2006) 0.86
Esophageal adenocarcinomas in heterotopic gastric mucosa: review and report of a case with complete response to neoadjuvant radiochemotherapy. Dig Surg (2005) 0.84
C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer (2005) 0.84
Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer). World J Surg (2003) 0.83
Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg (2014) 0.83
Tracheal bronchus associated with recurrent pneumonia. Ulster Med J (2013) 0.82
No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection. Mol Carcinog (2006) 0.82
Barrett's esophagus and Barrett's carcinoma. Curr Oncol Rep (2003) 0.82
Current concepts of percutaneous abscess drainage in postoperative retention. J Gastrointest Surg (2005) 0.81
Carcinoma of the cardia: classification as esophageal or gastric cancer? Int J Colorectal Dis (2004) 0.81
Endovascular stent--graft repair of a symptomatic superior mesenteric artery aneurysm. Ann Vasc Surg (2011) 0.80
Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer? Lancet Oncol (2007) 0.80
Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC). Eur J Radiol (2013) 0.80
Multimodal treatment of gastrointestinal tract tumors: consequences for surgery. World J Surg (2005) 0.80
Bile reflux in the constellation of gastroesophageal reflux disease. Thorac Surg Clin (2005) 0.80
Current outcome of esophagectomy in the very elderly: experience of a German high-volume center. Am Surg (2013) 0.80
Video-assisted thoracoscopic surgery for posttraumatic hemothorax in the very elderly. Thorac Cardiovasc Surg (2012) 0.79
Staging and treatment of advanced esophageal cancer. Curr Opin Gastroenterol (2005) 0.79
Pancreaticopleural fistula-induced empyema thoracis: principles and results of surgical management. Thorac Cardiovasc Surg (2013) 0.79
Current treatment approach to locally advanced esophageal cancer: is resection mandatory? Future Oncol (2006) 0.79
Therapy of advanced esophageal malignancy. Curr Opin Gastroenterol (2004) 0.79
The tale of spring water cysts: a historical outline of surgery for congenital pericardial diverticula and cysts. Tex Heart Inst J (2012) 0.79
Role of acid and bile in the genesis of Barrett's esophagus. Chest Surg Clin N Am (2002) 0.78
Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists. Bioorg Med Chem (2010) 0.78
Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences. Eur J Nucl Med Mol Imaging (2015) 0.78
Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma. World J Surg (2004) 0.78
Times and trends in the treatment of spontaneous perforation of the esophagus: from Herman Boerhaave to the present age. Am Surg (2013) 0.77
Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach. Int J Colorectal Dis (2013) 0.77
Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity. Arch Pharm (Weinheim) (2011) 0.77
Synthesis, characterization, and metabolism studies of fluspidine enantiomers. ChemMedChem (2013) 0.77
Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia. World J Surg (2003) 0.77
Modern history of surgical management of lung abscess: from Harold Neuhof to current concepts. Ann Thorac Surg (2011) 0.77